↓ Skip to main content

Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women

Overview of attention for article published in Cochrane database of systematic reviews, September 2010
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
106 Dimensions

Readers on

mendeley
277 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women
Published in
Cochrane database of systematic reviews, September 2010
DOI 10.1002/14651858.cd007063.pub2
Pubmed ID
Authors

Sharif I Ismail, Christine Bain, Suzanne Hagen

Abstract

Pelvic organ prolapse is common and can be detected in up to 50% of parous women although many are asymptomatic. Oestrogen preparations are used to improve vaginal thinning (atrophy). It is possible that oestrogens, alone or in conjunction with other interventions, might prevent or assist in the management of pelvic organ prolapse, for example by improving the strength of weakened supporting structures.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 276 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 43 16%
Student > Master 31 11%
Student > Ph. D. Student 20 7%
Other 18 6%
Researcher 18 6%
Other 64 23%
Unknown 83 30%
Readers by discipline Count As %
Medicine and Dentistry 107 39%
Nursing and Health Professions 34 12%
Agricultural and Biological Sciences 8 3%
Engineering 7 3%
Psychology 6 2%
Other 24 9%
Unknown 91 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2015.
All research outputs
#8,571,053
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#9,070
of 11,842 outputs
Outputs of similar age
#38,705
of 104,970 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 80 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,970 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.